| Effect and safety of Semaglutide in diabetic kidney transplant recipients with obesity |
Ongoing |
Anifrolumab |
3 |
2241130 |
Aseer Central Hospital (Abha), International Medical Center (Jeddah), King Khalid University Hospital (Riyadh) |
| Survey assessing prospective patient’s short-term treatment satisfaction and Quality of Life in patients with Hidradenitis Suppurativa initiated on Cosentyx (Secukinumab) in routine clinical practice in Saudi Arabia |
Ongoing |
Secukinumab |
4 |
CAIN457MSA |
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah),Medical Fakeeh Center (Jeddah) |
| Comparing the effectiveness of buccal infiltration of different volumes of Articaine for extraction of mandibular posterior teeth- A randomized clinical trial. |
Ongoing |
ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE |
4 |
6074514624 |
Dental Clinic-collage of Dentistry-Qassim Unviersity (Al-Qassim) |
| The ENERGY 2 Study: An Open-Label Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Infants with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency |
Ongoing |
INZ-701 |
3 |
INZ701-105 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Randomized, Double-Blinded, Placebo-Controlled, Phase 3, Parallel-Group Design Study Evaluating the Efficacy and Safety of Efgartigimod IV in Adult Participants With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis |
Ongoing |
Efgartigimod IV |
3 |
ARGX-113-2308 |
King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh) |
| INTERnational STudy Evaluating Lupus Outcomes after Anifrolumab Real-World Use (INTERSTELLAR): Multi-National, Observational, Prospective, Post-Launch, Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice |
Ongoing |
Anifrolumab |
4 |
TMP-0010230 |
Aseer Central Hospital (Abha), International Medical Center (Jeddah),King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah) |
| A prospective, randomized, double-blind, multicenter, placebo-controlled, parallel group, adaptive Phase 3 study with open-label extension to evaluate efficacy and safety of macitentan 75 mg in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension. |
Terminated |
Macitentan (ACT-064992, Opsumit ®) |
3 |
67896062CTP3001 |
King Fahad Medical City (Riyadh),King Faisal Specialist Hospital and Research Center (Riyadh) |
| Articaine efficacy and safety for 3 years old children: A Clinical Randomized Control Trial. |
Ongoing |
Articaine |
3 |
607-43-7809 |
Qassim Regional Dental Center,The One Clinic (Buraydah) |
| A Phase 3, Randomized, Double-blind, Placebo-controlled, Cross over Study of Oral Deucrictibant Soft Capsule for On Demand Treatment of Attacks in Adolescents and Adults with Hereditary Angioedema |
Ongoing |
Deucrictibant |
3 |
PHA022121-C306 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) |
Ongoing |
Nipocalimab |
3 |
80202135EBF3001 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar) |
